1 Study Coverage 1.1 Gemcitabine Injection Product Introduction 1.2 Market by Type 1.2.1 Global Gemcitabine Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 200mg/5.26 mL 1.2.3 1g/26.3 mL 1.2.4 2g/52.6 mL 1.3 Market by Application 1.3.1 Global Gemcitabine Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Gemcitabine Injection Sales Estimates and Forecasts 2017-2028 2.2 Global Gemcitabine Injection Revenue Estimates and Forecasts 2017-2028 2.3 Global Gemcitabine Injection Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Gemcitabine Injection Sales by Region 2.4.1 Global Gemcitabine Injection Sales by Region (2017-2022) 2.4.2 Global Sales Gemcitabine Injection by Region (2023-2028) 2.5 Global Gemcitabine Injection Revenue by Region 2.5.1 Global Gemcitabine Injection Revenue by Region (2017-2022) 2.5.2 Global Gemcitabine Injection Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Gemcitabine Injection Sales by Manufacturers 3.1.1 Global Top Gemcitabine Injection Manufacturers by Sales (2017-2022) 3.1.2 Global Gemcitabine Injection Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gemcitabine Injection in 2021 3.2 Global Gemcitabine Injection Revenue by Manufacturers 3.2.1 Global Gemcitabine Injection Revenue by Manufacturers (2017-2022) 3.2.2 Global Gemcitabine Injection Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Gemcitabine Injection Revenue in 2021 3.3 Global Gemcitabine Injection Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Gemcitabine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Gemcitabine Injection Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Gemcitabine Injection Sales by Type 4.1.1 Global Gemcitabine Injection Historical Sales by Type (2017-2022) 4.1.2 Global Gemcitabine Injection Forecasted Sales by Type (2023-2028) 4.1.3 Global Gemcitabine Injection Sales Market Share by Type (2017-2028) 4.2 Global Gemcitabine Injection Revenue by Type 4.2.1 Global Gemcitabine Injection Historical Revenue by Type (2017-2022) 4.2.2 Global Gemcitabine Injection Forecasted Revenue by Type (2023-2028) 4.2.3 Global Gemcitabine Injection Revenue Market Share by Type (2017-2028) 4.3 Global Gemcitabine Injection Price by Type 4.3.1 Global Gemcitabine Injection Price by Type (2017-2022) 4.3.2 Global Gemcitabine Injection Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Gemcitabine Injection Sales by Application 5.1.1 Global Gemcitabine Injection Historical Sales by Application (2017-2022) 5.1.2 Global Gemcitabine Injection Forecasted Sales by Application (2023-2028) 5.1.3 Global Gemcitabine Injection Sales Market Share by Application (2017-2028) 5.2 Global Gemcitabine Injection Revenue by Application 5.2.1 Global Gemcitabine Injection Historical Revenue by Application (2017-2022) 5.2.2 Global Gemcitabine Injection Forecasted Revenue by Application (2023-2028) 5.2.3 Global Gemcitabine Injection Revenue Market Share by Application (2017-2028) 5.3 Global Gemcitabine Injection Price by Application 5.3.1 Global Gemcitabine Injection Price by Application (2017-2022) 5.3.2 Global Gemcitabine Injection Price Forecast by Application (2023-2028) 6 North America 6.1 North America Gemcitabine Injection Market Size by Type 6.1.1 North America Gemcitabine Injection Sales by Type (2017-2028) 6.1.2 North America Gemcitabine Injection Revenue by Type (2017-2028) 6.2 North America Gemcitabine Injection Market Size by Application 6.2.1 North America Gemcitabine Injection Sales by Application (2017-2028) 6.2.2 North America Gemcitabine Injection Revenue by Application (2017-2028) 6.3 North America Gemcitabine Injection Market Size by Country 6.3.1 North America Gemcitabine Injection Sales by Country (2017-2028) 6.3.2 North America Gemcitabine Injection Revenue by Country (2017-2028) 6.3.3 United States 6.3.4 Canada 7 Europe 7.1 Europe Gemcitabine Injection Market Size by Type 7.1.1 Europe Gemcitabine Injection Sales by Type (2017-2028) 7.1.2 Europe Gemcitabine Injection Revenue by Type (2017-2028) 7.2 Europe Gemcitabine Injection Market Size by Application 7.2.1 Europe Gemcitabine Injection Sales by Application (2017-2028) 7.2.2 Europe Gemcitabine Injection Revenue by Application (2017-2028) 7.3 Europe Gemcitabine Injection Market Size by Country 7.3.1 Europe Gemcitabine Injection Sales by Country (2017-2028) 7.3.2 Europe Gemcitabine Injection Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Gemcitabine Injection Market Size by Type 8.1.1 Asia Pacific Gemcitabine Injection Sales by Type (2017-2028) 8.1.2 Asia Pacific Gemcitabine Injection Revenue by Type (2017-2028) 8.2 Asia Pacific Gemcitabine Injection Market Size by Application 8.2.1 Asia Pacific Gemcitabine Injection Sales by Application (2017-2028) 8.2.2 Asia Pacific Gemcitabine Injection Revenue by Application (2017-2028) 8.3 Asia Pacific Gemcitabine Injection Market Size by Region 8.3.1 Asia Pacific Gemcitabine Injection Sales by Region (2017-2028) 8.3.2 Asia Pacific Gemcitabine Injection Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Gemcitabine Injection Market Size by Type 9.1.1 Latin America Gemcitabine Injection Sales by Type (2017-2028) 9.1.2 Latin America Gemcitabine Injection Revenue by Type (2017-2028) 9.2 Latin America Gemcitabine Injection Market Size by Application 9.2.1 Latin America Gemcitabine Injection Sales by Application (2017-2028) 9.2.2 Latin America Gemcitabine Injection Revenue by Application (2017-2028) 9.3 Latin America Gemcitabine Injection Market Size by Country 9.3.1 Latin America Gemcitabine Injection Sales by Country (2017-2028) 9.3.2 Latin America Gemcitabine Injection Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Gemcitabine Injection Market Size by Type 10.1.1 Middle East and Africa Gemcitabine Injection Sales by Type (2017-2028) 10.1.2 Middle East and Africa Gemcitabine Injection Revenue by Type (2017-2028) 10.2 Middle East and Africa Gemcitabine Injection Market Size by Application 10.2.1 Middle East and Africa Gemcitabine Injection Sales by Application (2017-2028) 10.2.2 Middle East and Africa Gemcitabine Injection Revenue by Application (2017-2028) 10.3 Middle East and Africa Gemcitabine Injection Market Size by Country 10.3.1 Middle East and Africa Gemcitabine Injection Sales by Country (2017-2028) 10.3.2 Middle East and Africa Gemcitabine Injection Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Fresenius Kabi 11.1.1 Fresenius Kabi Corporation Information 11.1.2 Fresenius Kabi Overview 11.1.3 Fresenius Kabi Gemcitabine Injection Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Fresenius Kabi Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Fresenius Kabi Recent Developments 11.2 Teva Pharmaceuticals 11.2.1 Teva Pharmaceuticals Corporation Information 11.2.2 Teva Pharmaceuticals Overview 11.2.3 Teva Pharmaceuticals Gemcitabine Injection Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Teva Pharmaceuticals Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Teva Pharmaceuticals Recent Developments 11.3 Pfizer 11.3.1 Pfizer Corporation Information 11.3.2 Pfizer Overview 11.3.3 Pfizer Gemcitabine Injection Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Pfizer Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Pfizer Recent Developments 11.4 Mylan Inc 11.4.1 Mylan Inc Corporation Information 11.4.2 Mylan Inc Overview 11.4.3 Mylan Inc Gemcitabine Injection Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Mylan Inc Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Mylan Inc Recent Developments 11.5 Novartis AG 11.5.1 Novartis AG Corporation Information 11.5.2 Novartis AG Overview 11.5.3 Novartis AG Gemcitabine Injection Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Novartis AG Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Novartis AG Recent Developments 11.6 Accord Healthcare 11.6.1 Accord Healthcare Corporation Information 11.6.2 Accord Healthcare Overview 11.6.3 Accord Healthcare Gemcitabine Injection Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Accord Healthcare Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Accord Healthcare Recent Developments 11.7 Meitheal Pharmaceuticals 11.7.1 Meitheal Pharmaceuticals Corporation Information 11.7.2 Meitheal Pharmaceuticals Overview 11.7.3 Meitheal Pharmaceuticals Gemcitabine Injection Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Meitheal Pharmaceuticals Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Meitheal Pharmaceuticals Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Gemcitabine Injection Industry Chain Analysis 12.2 Gemcitabine Injection Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Gemcitabine Injection Production Mode & Process 12.4 Gemcitabine Injection Sales and Marketing 12.4.1 Gemcitabine Injection Sales Channels 12.4.2 Gemcitabine Injection Distributors 12.5 Gemcitabine Injection Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Gemcitabine Injection Industry Trends 13.2 Gemcitabine Injection Market Drivers 13.3 Gemcitabine Injection Market Challenges 13.4 Gemcitabine Injection Market Restraints 14 Key Findings in The Global Gemcitabine Injection Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Gemcitabine Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of 200mg/5.26 mL Table 3. Major Manufacturers of 1g/26.3 mL Table 4. Major Manufacturers of 2g/52.6 mL Table 5. Global Gemcitabine Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Gemcitabine Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Gemcitabine Injection Sales by Region (2017-2022) & (KL) Table 8. Global Gemcitabine Injection Sales Market Share by Region (2017-2022) Table 9. Global Gemcitabine Injection Sales by Region (2023-2028) & (KL) Table 10. Global Gemcitabine Injection Sales Market Share by Region (2023-2028) Table 11. Global Gemcitabine Injection Revenue by Region (2017-2022) & (US$ Million) Table 12. Global Gemcitabine Injection Revenue Market Share by Region (2017-2022) Table 13. Global Gemcitabine Injection Revenue by Region (2023-2028) & (US$ Million) Table 14. Global Gemcitabine Injection Revenue Market Share by Region (2023-2028) Table 15. Global Gemcitabine Injection Sales by Manufacturers (2017-2022) & (KL) Table 16. Global Gemcitabine Injection Sales Share by Manufacturers (2017-2022) Table 17. Global Gemcitabine Injection Revenue by Manufacturers (2017-2022) & (US$ Million) Table 18. Global Gemcitabine Injection Revenue Share by Manufacturers (2017-2022) Table 19. Gemcitabine Injection Price by Manufacturers (2017-2022) &(US$/L) Table 20. Global Gemcitabine Injection Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Gemcitabine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gemcitabine Injection as of 2021) Table 22. Gemcitabine Injection Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Gemcitabine Injection Product Offered Table 24. Date of Manufacturers Enter into Gemcitabine Injection Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Gemcitabine Injection Sales by Type (2017-2022) & (KL) Table 27. Global Gemcitabine Injection Sales by Type (2023-2028) & (KL) Table 28. Global Gemcitabine Injection Sales Share by Type (2017-2022) Table 29. Global Gemcitabine Injection Sales Share by Type (2023-2028) Table 30. Global Gemcitabine Injection Revenue by Type (2017-2022) & (US$ Million) Table 31. Global Gemcitabine Injection Revenue by Type (2023-2028) & (US$ Million) Table 32. Global Gemcitabine Injection Revenue Share by Type (2017-2022) Table 33. Global Gemcitabine Injection Revenue Share by Type (2023-2028) Table 34. Gemcitabine Injection Price by Type (2017-2022) & (US$/L) Table 35. Global Gemcitabine Injection Price Forecast by Type (2023-2028) & (US$/L) Table 36. Global Gemcitabine Injection Sales by Application (2017-2022) & (KL) Table 37. Global Gemcitabine Injection Sales by Application (2023-2028) & (KL) Table 38. Global Gemcitabine Injection Sales Share by Application (2017-2022) Table 39. Global Gemcitabine Injection Sales Share by Application (2023-2028) Table 40. Global Gemcitabine Injection Revenue by Application (2017-2022) & (US$ Million) Table 41. Global Gemcitabine Injection Revenue by Application (2023-2028) & (US$ Million) Table 42. Global Gemcitabine Injection Revenue Share by Application (2017-2022) Table 43. Global Gemcitabine Injection Revenue Share by Application (2023-2028) Table 44. Gemcitabine Injection Price by Application (2017-2022) & (US$/L) Table 45. Global Gemcitabine Injection Price Forecast by Application (2023-2028) & (US$/L) Table 46. North America Gemcitabine Injection Sales by Type (2017-2022) & (KL) Table 47. North America Gemcitabine Injection Sales by Type (2023-2028) & (KL) Table 48. North America Gemcitabine Injection Revenue by Type (2017-2022) & (US$ Million) Table 49. North America Gemcitabine Injection Revenue by Type (2023-2028) & (US$ Million) Table 50. North America Gemcitabine Injection Sales by Application (2017-2022) & (KL) Table 51. North America Gemcitabine Injection Sales by Application (2023-2028) & (KL) Table 52. North America Gemcitabine Injection Revenue by Application (2017-2022) & (US$ Million) Table 53. North America Gemcitabine Injection Revenue by Application (2023-2028) & (US$ Million) Table 54. North America Gemcitabine Injection Sales by Country (2017-2022) & (KL) Table 55. North America Gemcitabine Injection Sales by Country (2023-2028) & (KL) Table 56. North America Gemcitabine Injection Revenue by Country (2017-2022) & (US$ Million) Table 57. North America Gemcitabine Injection Revenue by Country (2023-2028) & (US$ Million) Table 58. Europe Gemcitabine Injection Sales by Type (2017-2022) & (KL) Table 59. Europe Gemcitabine Injection Sales by Type (2023-2028) & (KL) Table 60. Europe Gemcitabine Injection Revenue by Type (2017-2022) & (US$ Million) Table 61. Europe Gemcitabine Injection Revenue by Type (2023-2028) & (US$ Million) Table 62. Europe Gemcitabine Injection Sales by Application (2017-2022) & (KL) Table 63. Europe Gemcitabine Injection Sales by Application (2023-2028) & (KL) Table 64. Europe Gemcitabine Injection Revenue by Application (2017-2022) & (US$ Million) Table 65. Europe Gemcitabine Injection Revenue by Application (2023-2028) & (US$ Million) Table 66. Europe Gemcitabine Injection Sales by Country (2017-2022) & (KL) Table 67. Europe Gemcitabine Injection Sales by Country (2023-2028) & (KL) Table 68. Europe Gemcitabine Injection Revenue by Country (2017-2022) & (US$ Million) Table 69. Europe Gemcitabine Injection Revenue by Country (2023-2028) & (US$ Million) Table 70. Asia Pacific Gemcitabine Injection Sales by Type (2017-2022) & (KL) Table 71. Asia Pacific Gemcitabine Injection Sales by Type (2023-2028) & (KL) Table 72. Asia Pacific Gemcitabine Injection Revenue by Type (2017-2022) & (US$ Million) Table 73. Asia Pacific Gemcitabine Injection Revenue by Type (2023-2028) & (US$ Million) Table 74. Asia Pacific Gemcitabine Injection Sales by Application (2017-2022) & (KL) Table 75. Asia Pacific Gemcitabine Injection Sales by Application (2023-2028) & (KL) Table 76. Asia Pacific Gemcitabine Injection Revenue by Application (2017-2022) & (US$ Million) Table 77. Asia Pacific Gemcitabine Injection Revenue by Application (2023-2028) & (US$ Million) Table 78. Asia Pacific Gemcitabine Injection Sales by Region (2017-2022) & (KL) Table 79. Asia Pacific Gemcitabine Injection Sales by Region (2023-2028) & (KL) Table 80. Asia Pacific Gemcitabine Injection Revenue by Region (2017-2022) & (US$ Million) Table 81. Asia Pacific Gemcitabine Injection Revenue by Region (2023-2028) & (US$ Million) Table 82. Latin America Gemcitabine Injection Sales by Type (2017-2022) & (KL) Table 83. Latin America Gemcitabine Injection Sales by Type (2023-2028) & (KL) Table 84. Latin America Gemcitabine Injection Revenue by Type (2017-2022) & (US$ Million) Table 85. Latin America Gemcitabine Injection Revenue by Type (2023-2028) & (US$ Million) Table 86. Latin America Gemcitabine Injection Sales by Application (2017-2022) & (KL) Table 87. Latin America Gemcitabine Injection Sales by Application (2023-2028) & (KL) Table 88. Latin America Gemcitabine Injection Revenue by Application (2017-2022) & (US$ Million) Table 89. Latin America Gemcitabine Injection Revenue by Application (2023-2028) & (US$ Million) Table 90. Latin America Gemcitabine Injection Sales by Country (2017-2022) & (KL) Table 91. Latin America Gemcitabine Injection Sales by Country (2023-2028) & (KL) Table 92. Latin America Gemcitabine Injection Revenue by Country (2017-2022) & (US$ Million) Table 93. Latin America Gemcitabine Injection Revenue by Country (2023-2028) & (US$ Million) Table 94. Middle East and Africa Gemcitabine Injection Sales by Type (2017-2022) & (KL) Table 95. Middle East and Africa Gemcitabine Injection Sales by Type (2023-2028) & (KL) Table 96. Middle East and Africa Gemcitabine Injection Revenue by Type (2017-2022) & (US$ Million) Table 97. Middle East and Africa Gemcitabine Injection Revenue by Type (2023-2028) & (US$ Million) Table 98. Middle East and Africa Gemcitabine Injection Sales by Application (2017-2022) & (KL) Table 99. Middle East and Africa Gemcitabine Injection Sales by Application (2023-2028) & (KL) Table 100. Middle East and Africa Gemcitabine Injection Revenue by Application (2017-2022) & (US$ Million) Table 101. Middle East and Africa Gemcitabine Injection Revenue by Application (2023-2028) & (US$ Million) Table 102. Middle East and Africa Gemcitabine Injection Sales by Country (2017-2022) & (KL) Table 103. Middle East and Africa Gemcitabine Injection Sales by Country (2023-2028) & (KL) Table 104. Middle East and Africa Gemcitabine Injection Revenue by Country (2017-2022) & (US$ Million) Table 105. Middle East and Africa Gemcitabine Injection Revenue by Country (2023-2028) & (US$ Million) Table 106. Fresenius Kabi Corporation Information Table 107. Fresenius Kabi Description and Major Businesses Table 108. Fresenius Kabi Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2017-2022) Table 109. Fresenius Kabi Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications Table 110. Fresenius Kabi Recent Developments Table 111. Teva Pharmaceuticals Corporation Information Table 112. Teva Pharmaceuticals Description and Major Businesses Table 113. Teva Pharmaceuticals Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2017-2022) Table 114. Teva Pharmaceuticals Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications Table 115. Teva Pharmaceuticals Recent Developments Table 116. Pfizer Corporation Information Table 117. Pfizer Description and Major Businesses Table 118. Pfizer Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2017-2022) Table 119. Pfizer Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications Table 120. Pfizer Recent Developments Table 121. Mylan Inc Corporation Information Table 122. Mylan Inc Description and Major Businesses Table 123. Mylan Inc Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2017-2022) Table 124. Mylan Inc Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications Table 125. Mylan Inc Recent Developments Table 126. Novartis AG Corporation Information Table 127. Novartis AG Description and Major Businesses Table 128. Novartis AG Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2017-2022) Table 129. Novartis AG Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications Table 130. Novartis AG Recent Developments Table 131. Accord Healthcare Corporation Information Table 132. Accord Healthcare Description and Major Businesses Table 133. Accord Healthcare Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2017-2022) Table 134. Accord Healthcare Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications Table 135. Accord Healthcare Recent Developments Table 136. Meitheal Pharmaceuticals Corporation Information Table 137. Meitheal Pharmaceuticals Description and Major Businesses Table 138. Meitheal Pharmaceuticals Gemcitabine Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2017-2022) Table 139. Meitheal Pharmaceuticals Gemcitabine Injection Product Model Numbers, Pictures, Descriptions and Specifications Table 140. Meitheal Pharmaceuticals Recent Developments Table 141. Key Raw Materials Lists Table 142. Raw Materials Key Suppliers Lists Table 143. Gemcitabine Injection Distributors List Table 144. Gemcitabine Injection Customers List Table 145. Gemcitabine Injection Market Trends Table 146. Gemcitabine Injection Market Drivers Table 147. Gemcitabine Injection Market Challenges Table 148. Gemcitabine Injection Market Restraints Table 149. Research Programs/Design for This Report Table 150. Key Data Information from Secondary Sources Table 151. Key Data Information from Primary Sources List of Figures Figure 1. Gemcitabine Injection Product Picture Figure 3. Global Gemcitabine Injection Market Share by Type in 2021 & 2028 Figure 3. 200mg/5.26 mL Product Picture Figure 4. 1g/26.3 mL Product Picture Figure 5. 2g/52.6 mL Product Picture Figure 6. Global Gemcitabine Injection Market Share by Application in 2021 & 2028 Figure 7. Hospital Figure 8. Clinic Figure 9. Gemcitabine Injection Report Years Considered Figure 10. Global Gemcitabine Injection Sales 2017-2028 (KL) Figure 11. Global Gemcitabine Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Gemcitabine Injection Revenue 2017-2028 (US$ Million) Figure 13. Global Gemcitabine Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 14. Global Gemcitabine Injection Sales Market Share by Region (2017-2022) Figure 15. Global Gemcitabine Injection Sales Market Share by Region (2023-2028) Figure 16. North America Gemcitabine Injection Sales YoY (2017-2028) & (KL) Figure 17. North America Gemcitabine Injection Revenue YoY (2017-2028) & (US$ Million) Figure 18. Europe Gemcitabine Injection Sales YoY (2017-2028) & (KL) Figure 19. Europe Gemcitabine Injection Revenue YoY (2017-2028) & (US$ Million) Figure 20. Asia-Pacific Gemcitabine Injection Sales YoY (2017-2028) & (KL) Figure 21. Asia-Pacific Gemcitabine Injection Revenue YoY (2017-2028) & (US$ Million) Figure 22. Latin America Gemcitabine Injection Sales YoY (2017-2028) & (KL) Figure 23. Latin America Gemcitabine Injection Revenue YoY (2017-2028) & (US$ Million) Figure 24. Middle East & Africa Gemcitabine Injection Sales YoY (2017-2028) & (KL) Figure 25. Middle East & Africa Gemcitabine Injection Revenue YoY (2017-2028) & (US$ Million) Figure 26. The Gemcitabine Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 27. The Top 5 and 10 Largest Manufacturers of Gemcitabine Injection in the World: Market Share by Gemcitabine Injection Revenue in 2021 Figure 28. Global Gemcitabine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 29. Global Gemcitabine Injection Sales Market Share by Type (2017-2028) Figure 30. Global Gemcitabine Injection Revenue Market Share by Type (2017-2028) Figure 31. Global Gemcitabine Injection Sales Market Share by Application (2017-2028) Figure 32. Global Gemcitabine Injection Revenue Market Share by Application (2017-2028) Figure 33. North America Gemcitabine Injection Sales Market Share by Type (2017-2028) Figure 34. North America Gemcitabine Injection Revenue Market Share by Type (2017-2028) Figure 35. North America Gemcitabine Injection Sales Market Share by Application (2017-2028) Figure 36. North America Gemcitabine Injection Revenue Market Share by Application (2017-2028) Figure 37. North America Gemcitabine Injection Sales Share by Country (2017-2028) Figure 38. North America Gemcitabine Injection Revenue Share by Country (2017-2028) Figure 39. United States Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 40. Canada Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 41. Europe Gemcitabine Injection Sales Market Share by Type (2017-2028) Figure 42. Europe Gemcitabine Injection Revenue Market Share by Type (2017-2028) Figure 43. Europe Gemcitabine Injection Sales Market Share by Application (2017-2028) Figure 44. Europe Gemcitabine Injection Revenue Market Share by Application (2017-2028) Figure 45. Europe Gemcitabine Injection Sales Share by Country (2017-2028) Figure 46. Europe Gemcitabine Injection Revenue Share by Country (2017-2028) Figure 47. Germany Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 48. France Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 49. U.K. Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 50. Italy Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 51. Russia Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 52. Asia Pacific Gemcitabine Injection Sales Market Share by Type (2017-2028) Figure 53. Asia Pacific Gemcitabine Injection Revenue Market Share by Type (2017-2028) Figure 54. Asia Pacific Gemcitabine Injection Sales Market Share by Application (2017-2028) Figure 55. Asia Pacific Gemcitabine Injection Revenue Market Share by Application (2017-2028) Figure 56. Asia Pacific Gemcitabine Injection Sales Share by Region (2017-2028) Figure 57. Asia Pacific Gemcitabine Injection Revenue Share by Region (2017-2028) Figure 58. China Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 59. Japan Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 60. South Korea Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 61. India Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 62. Australia Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 63. China Taiwan Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 64. Indonesia Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 65. Thailand Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 66. Malaysia Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 67. Latin America Gemcitabine Injection Sales Market Share by Type (2017-2028) Figure 68. Latin America Gemcitabine Injection Revenue Market Share by Type (2017-2028) Figure 69. Latin America Gemcitabine Injection Sales Market Share by Application (2017-2028) Figure 70. Latin America Gemcitabine Injection Revenue Market Share by Application (2017-2028) Figure 71. Latin America Gemcitabine Injection Sales Share by Country (2017-2028) Figure 72. Latin America Gemcitabine Injection Revenue Share by Country (2017-2028) Figure 73. Mexico Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 74. Brazil Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 75. Argentina Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 76. Middle East and Africa Gemcitabine Injection Sales Market Share by Type (2017-2028) Figure 77. Middle East and Africa Gemcitabine Injection Revenue Market Share by Type (2017-2028) Figure 78. Middle East and Africa Gemcitabine Injection Sales Market Share by Application (2017-2028) Figure 79. Middle East and Africa Gemcitabine Injection Revenue Market Share by Application (2017-2028) Figure 80. Middle East and Africa Gemcitabine Injection Sales Share by Country (2017-2028) Figure 81. Middle East and Africa Gemcitabine Injection Revenue Share by Country (2017-2028) Figure 82. Turkey Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 83. Saudi Arabia Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 84. UAE Gemcitabine Injection Revenue (2017-2028) & (US$ Million) Figure 85. Gemcitabine Injection Value Chain Figure 86. Gemcitabine Injection Production Process Figure 87. Channels of Distribution Figure 88. Distributors Profiles Figure 89. Bottom-up and Top-down Approaches for This Report Figure 90. Data Triangulation Figure 91. Key Executives Interviewed

Fresenius Kabi Teva Pharmaceuticals Pfizer Mylan Inc Novartis AG Accord Healthcare Meitheal Pharmaceuticals